Related Experiment Videos
CTNS mutations in patients with cystinosis
Y Anikster1, V Shotelersuk, W A Gahl
1Section on Human Biochemical Genetics, Heritable Disorders Branch, National Institute of Child Health and Human Development, Bethesda, Maryland 20892-1830, USA.
Human Mutation
|November 26, 1999
Summary
Cystinosis is a genetic disorder caused by CTNS gene mutations, affecting cystine transport. Different mutations lead to varying disease severity, from infantile nephropathic to benign forms.
Area of Science:
- Genetics
- Molecular Biology
- Biochemistry
Background:
- Cystinosis is an autosomal recessive lysosomal storage disease.
- It results from mutations in the CTNS gene, encoding the lysosomal cystine transporter cystinosin.
- The nephropathic form typically leads to renal failure by age 10.
Purpose of the Study:
- To review the spectrum of CTNS mutations associated with cystinosis.
- To correlate specific CTNS mutations with different clinical phenotypes of cystinosis.
Main Methods:
- Review of published CTNS mutation data in cystinosis patients.
- Classification of mutations based on associated clinical presentation (nephropathic, intermediate, benign).
Main Results:
- 32 distinct CTNS mutations identified in nephropathic cystinosis.
- 3 CTNS mutations linked to intermediate cystinosis.
- 2 CTNS mutations associated with benign cystinosis.
- Splicing and missense mutations generally correlate with milder phenotypes.
Conclusions:
- CTNS mutation analysis is crucial for understanding cystinosis.
- Genotype-phenotype correlations in CTNS mutations help predict disease severity.
- Further research into CTNS mutations can inform therapeutic strategies.